Melanin and melanogenesis in adipose tissue: Possible mechanisms for abating oxidative stress and inflammation?

Obesity Reviews

Volumn 12, Issue 5, 2011, Pages

  Page, S ^a,b   Chandhoke, V ^a   Baranova, A ^a,b  

^a GEORGE MASON UNIVERSITY   (United States)

^b INOVA FAIRFAX HOSPITAL   (United States)

Author keywords

Inflammation; Melanin; Metabolic syndrome; Obesity

Indexed keywords

AFAMELANOTIDE; ALPHA INTERMEDIN; MELANIN; MELANOCORTIN; REACTIVE OXYGEN METABOLITE;

ADIPOSE TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ERECTILE DYSFUNCTION; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MELANOGENESIS; NONALCOHOLIC FATTY LIVER; OBESITY; OXIDATIVE STRESS; PREVENTIVE MEDICINE;

EID: 79955043476     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/j.1467-789X.2010.00773.x     Document Type: Article

References (100)

1. World Health Organization. Obesity and overweight. 2009. [WWW document]. URL (accessed 10 June 2010).
2. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549-1555.
3. Caballeria L, Auladell MA, Toran P, Pera G, Miranda D, Aluma A, Casas JD, Munoz L, Sanchez C, Tibau A, Birules M, Canut S, Bernad J, Auba J, Aizpurua MM, Alcaraz E. Risk factors associated with non-alcoholic fatty liver disease in subjects from primary care units. A case-control study. BMC Gastroenterol 2008; 8: 44.
4. Wild SH, Byrne CD. ABC of obesity. Risk factors for diabetes and coronary heart disease. BMJ 2006; 333: 1009-1011.
5. Jarrar MH, Baranova A, Collantes R, Ranard B, Stepanova M, Bennett C, Fang Y, Elariny H, Goodman Z, Chandhoke V, Younossi ZM. Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2008; 27: 412-421.
6. Nakamuta M, Kohjima M, Higuchi N, Kato M, Kotoh K, Yoshimoto T, Yada M, Yada R, Takemoto R, Fukuizumi K, Harada N, Taketomi A, Maehara Y, Nakashima M, Enjoji M. The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease. Int J Mol Med 2008; 22: 663-667.
7. Andreassi MG. Metabolic syndrome, diabetes and atherosclerosis: influence of gene-environment interaction. Mutat Res 2009; 667: 35-43.
8. Qi L, Cho YA. Gene-environment interaction and obesity. Nutr Rev 2008; 66: 684-694.
9. Romao I, Roth J. Genetic and environmental interactions in obesity and type 2 diabetes. J Am Diet Assoc 2008; 108: S24-S28.
10. O'Rourke RW. Inflammation in obesity-related diseases. Surgery 2009; 145: 255-259.
11. Karalis KP, Giannogonas P, Kodela E, Koutmani Y, Zoumakis M, Teli T. Mechanisms of obesity and related pathology: linking immune responses to metabolic stress. FEBS J 2009; 276: 5747-5754.
12. Nathan C. Epidemic inflammation: pondering obesity. Mol Med 2008; 14: 485-492.
13. Song MJ, Kim KH, Yoon JM, Kim JB. Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem Biophys Res Commun 2006; 346: 739-745.
14. de Luca C, Olefsky JM. Inflammation and insulin resistance. FEBS Lett 2008; 582: 97-105.
15. Wang B, Wood IS, Trayhurn P. Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes. Pflugers Arch 2007; 455: 479-492.
16. Skurk T, Alberti-Huber C, Herder C, Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 2007; 92: 1023-1033.
17. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW, Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808.
18. Fain JN. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 2006; 74: 443-477.
19. Fain JN, Buehrer B, Bahouth SW, Tichansky DS, Madan AK. Comparison of messenger RNA distribution for 60 proteins in fat cells vs the nonfat cells of human omental adipose tissue. Metabolism 2008; 57: 1005-1015.
20. Bluher M. The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol 2009.
21. Wildman RP. Healthy obesity. Curr Opin Clin Nutr Metab Care 2009; 12: 438-443.
22. Fujita K, Nishizawa H, Funahashi T, Shimomura I, Shimabukuro M. Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circ J 2006; 70: 1437-1442.
23. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752-1761.
24. Coyne T, Ibiebele TI, Baade PD, McClintock CS, Shaw JE. Metabolic syndrome and serum carotenoids: findings of a cross-sectional study in Queensland, Australia. Br J Nutr 2009; 102: 1668-1677.
25. Hagiwara S, Gohda T, Tanimoto M, Ito T, Murakoshi M, Ohara I, Yamazaki T, Matsumoto M, Horikoshi S, Funabiki K, Tomino Y. Effects of pyridoxamine (K-163) on glucose intolerance and obesity in high-fat diet C57BL/6J mice. Metabolism 2009; 58: 934-945.
26. Rivera L, Morón R, Zarzuelo A, Galisteo M. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem Pharmacol 2009; 77: 1053-1063.
27. Randhawa M, Huff T, Valencia JC, Younossi Z, Chandhoke V, Hearing VJ, Baranova A. Evidence for the ectopic synthesis of melanin in human adipose tissue. FASEB J 2009; 23: 835-843.
28. Vincent HK, Taylor AG. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes (Lond) 2006; 30: 400-418.
29. Di Girolamo M, Esposito G. Adipose tissue blood flow and cellularity in the growing rabbit. Am J Physiol 1975; 229: 107-112.
30. Kabon B, Nagele A, Reddy D, Eagon C, Fleshman JW, Sessler DI, Kurz A. Obesity decreases perioperative tissue oxygenation. Anesthesiology 2004; 100: 274-280.
31. Trayhurn P, Wang B, Wood IS. Hypoxia and the endocrine and signalling role of white adipose tissue. Arch Physiol Biochem 2008; 114: 267-276.
32. Guzy RD, Hoyos B, Robin E, Chen H, Liu L, Mansfield KD, Simon MC, Hammerling U, Schumacker PT. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab 2005; 1: 401-408.
33. Glassford AJ, Yue P, Sheikh AY, Chun HJ, Zarafshar S, Chan DA, Reaven GM, Quertermous T, Tsao PS. HIF-1 regulates hypoxia- and insulin-induced expression of apelin in adipocytes. Am J Physiol 2007; 293: E1590-E1596.
34. Chen R, Yang L, McIntyre TM. Cytotoxic phospholipid oxidation products. Cell death from mitochondrial damage and the intrinsic caspase cascade. J Biol Chem 2007; 282: 24842-24850.
35. Bergamini CM, Gambetti S, Dondi A, Cervellati C. Oxygen, reactive oxygen species and tissue damage. Curr Pharm Des 2004; 10: 1611-1626.
36. Ito S, Wakamatsu K. Melanin chemistry and melanin precursors in melanoma. J Invest Dermatol 1989; 92: 261S-265S.
37. Nofsinger JB, Liu Y, Simon JD. Aggregation of eumelanin mitigates photogeneration of reactive oxygen species. Free Radic Biol Med 2002; 32: 720-730.
38. Sarna T. Properties and function of the ocular melanin - a photobiophysical view. J Photochem Photobiol 1992; 12: 215-258.
39. Park HY, Kosmadaki M, Yaar M, Gilchrest BA. Cellular mechanisms regulating human melanogenesis. Cell Mol Life Sci 2009; 66: 1493-1506.
40. Brzoska T, Luger TA, Maaser C, Abels C, Bohm M. A-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocr Rev 2008; 29: 581-602.
41. Busca R, Ballotti R. Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res 2000; 13: 60-69.
42. Ito S, Wakamatsu K. Quantitative analysis of eumelanin and pheomelanin in humans, mice, and other animals: a comparative review. Pigment cell research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society. 2003; 16: 523-531.
43. Schallreuter KU, Kothari S, Chavan B, Spencer JD. Regulation of melanogenesis - controversies and new concepts. Exp Dermatol 2008; 17: 395-404.
44. Hallschmid M, Benedict C, Born J, Fehm HL, Kern W. Manipulating central nervous mechanisms of food intake and body weight regulation by intranasal administration of neuropeptides in man. Physiol Behav 2004; 83: 55-64.
45. Prota G. Melanins and Melanogenesis. Academic Press: San Diego, CA, 1992.
46. Wolbarsht ML, Walsh AW, George G. Melanin, a unique biological absorber. Appl Opt 1981; 20: 2184-2186.
47. Herrling T, Jung K, Fuchs J. The role of melanin as protector against free radicals in skin and its role as free radical indicator in hair. Spectrochim Acta 2008; 69: 1429-1435.
48. Kobayashi N, Nakagawa A, Muramatsu T, Yamashina Y, Shirai T, Hashimoto MW, Ishigaki Y, Ohnishi T, Mori T. Supranuclear melanin caps reduce ultraviolet induced DNA photoproducts in human epidermis. J Invest Dermatol 1998; 110: 806-810.
49. Montagna W, Carlisle K. The architecture of black and white facial skin. J Am Acad Dermatol 1991; 24: 929-937.
50. Takeuchi S, Zhang W, Wakamatsu K, Ito S, Hearing VJ, Kraemer KH, Brash DE. Melanin acts as a potent UVB photosensitizer to cause an atypical mode of cell death in murine skin. Proc Natl Acad Sci U S A 2004; 101: 15076-15081.
51. Krol ES, Liebler DC. Photoprotective actions of natural and synthetic melanins. Chem Res Toxicol 1998; 11: 1434-1440.
52. Morelli JG, Norris DA. Influence of inflammatory mediators and cytokines on human melanocyte function. J Invest Dermatol 1993; 100: 191S-195S.
53. Tomita Y, Maeda K, Tagami H. Melanocyte-stimulating properties of arachidonic acid metabolites: possible role in postinflammatory pigmentation. Pigment cell research/sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society. 1992; 5: 357-361.
54. Rozanowska M, Sarna T, Land EJ, Truscott TG. Free radical scavenging properties of melanin interaction of eu- and pheo-melanin models with reducing and oxidising radicals. Free Radic Biol Med 1999; 26: 518-525.
55. Seagle BL, Rezai KA, Gasyna EM, Kobori Y, Rezaei KA, Norris JR, Jr. Time-resolved detection of melanin free radicals quenching reactive oxygen species. J Am Chem Soc 2005; 127: 11220-11221.
56. Bustamante J, Bredeston L, Malanga G, Mordoh J. Role of melanin as a scavenger of active oxygen species. Pigment cell research/sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society. 1993; 6: 348-353.
57. Sarna T, Menon IA, Sealy RC. Photosensitization of melanins: a comparative study. Photochem Photobiol 1985; 42: 529-532.
58. Sealy RC, Sarna T, Wanner EJ, Reszka K. Photosensitization of melanin: an electron spin resonance study of sensitized radical production and oxygen consumption. Photochem Photobiol 1984; 40: 453-459.
59. Sarna T, Pilas B, Land EJ, Truscott TG. Interaction of radicals from water radiolysis with melanin. Biochim Biophys Acta 1986; 883: 162-167.
60. Korytowski W, Kalyanaraman B, Menon IA, Sarna T, Sealy RC. Reaction of superoxide anions with melanins: electron spin resonance and spin trapping studies. Biochim Biophys Acta 1986; 882: 145-153.
61. Ezzahir A. The influence of melanins on the photoperoxidation of lipids. J Photochem Photobiol 1989; 3: 341-349.
62. Porebska-Budny M, Sakina NL, Stepien KB, Dontsov AE, Wilczok T. Antioxidative activity of synthetic melanins. Cardiolipin liposome model. Biochim Biophys Acta 1992; 1116: 11-16.
63. Schmitz S, Thomas PD, Allen TM, Poznansky MJ, Jimbow K. Dual role of melanins and melanin precursors as photoprotective and phototoxic agents: inhibition of ultraviolet radiation-induced lipid peroxidation. Photochem Photobiol 1995; 61: 650-655.
64. Mohagheghpour N, Waleh N, Garger SJ, Dousman L, Grill LK, Tuse D. Synthetic melanin suppresses production of proinflammatory cytokines. Cell Immunol 2000; 199: 25-36.
65. Luger TA, Schauer E, Trautinger F, Krutmann J, Ansel J, Schwarz A, Schwarz T. Production of immunosuppressing melanotropins by human keratinocytes. Ann N Y Acad Sci 1993; 680: 567-570.
66. Rajora N, Boccoli G, Burns D, Sharma S, Catania AP, Lipton JM. α-MSH modulates local and circulating tumor necrosis factor-α in experimental brain inflammation. J Neurosci 1997; 17: 2181-2186.
67. Getting SJ, Christian HC, Flower RJ, Perretti M. Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis. Arthritis Rheum 2002; 46: 2765-2775.
68. Colombo G, Buffa R, Bardella MT, Garofalo L, Carlin A, Lipton JM, Catania A. Anti-inflammatory effects of α-melanocyte-stimulating hormone in celiac intestinal mucosa. Neuroimmunomodulation 2002; 10: 208-216.
69. Bohm M, Schiller M, Stander S, Seltmann H, Li Z, Brzoska T, Metze D, Schioth HB, Skottner A, Seiffert K, Zouboulis CC, Luger TA. Evidence for expression of melanocortin-1 receptor in human sebocytes in vitro and in situ. J Invest Dermatol 2002; 118: 533-539.
70. Brzoska T, Kalden DH, Scholzen T, Luger TA. Molecular basis of the α-MSH/IL-1 antagonism. Ann N Y Acad Sci 1999; 885: 230-238.
71. Manna SK, Sarkar A, Sreenivasan Y. A-melanocyte-stimulating hormone down-regulates CXC receptors through activation of neutrophil elastase. Eur J Immunol 2006; 36: 754-769.
72. Bhardwaj RS, Schwarz A, Becher E, Mahnke K, Aragane Y, Schwarz T, Luger TA. Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes. J Immunol 1996; 156: 2517-2521.
73. Morandini R, Boeynaems JM, Hedley SJ, MacNeil S, Ghanem G. Modulation of ICAM-1 expression by α-MSH in human melanoma cells and melanocytes. J Cell Physiol 1998; 175: 276-282.
74. Star RA, Rajora N, Huang J, Stock RC, Catania A, Lipton JM. Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone. Proc Natl Acad Sci U S A 1995; 92: 8016-8020.
75. Yoon SW, Chun JS, Sung MH, Kim JY, Poo H. alpha-MSH inhibits TNF-α-induced matrix metalloproteinase-13 expression by modulating p38 kinase and nuclear factor kappaB signaling in human chondrosarcoma HTB-94 cells. Osteoarthritis and cartilage/OARS, Osteoarthritis Research Society. 2008; 16: 115-124.
76. Oktar BK, Yuksel M, Alican I. The role of cyclooxygenase inhibition in the effect of α-melanocyte-stimulating hormone on reactive oxygen species production by rat peritoneal neutrophils. Prostaglandins Leukot Essent Fatty Acids 2004; 71: 1-5.
77. Zou L, Sato N, Kone BC. A-melanocyte stimulating hormone protects against H2O2-induced inhibition of wound restitution in IEC-6 cells via a Syk kinase- and NF-kappabeta-dependent mechanism. Shock 2004; 22: 453-459.
78. Murphy MT, Richards DB, Lipton JM. Antipyretic potency of centrally administered α-melanocyte stimulating hormone. Science 1983; 221: 192-193.
79. Kokot A, Sindrilaru A, Schiller S, Sunderkoetter C, Kerkhoff C, Scharffetter-Kochanek K, Luger TA. Bohm M. α-melanocyte-stimulating hormone is a powerful agent in the bleomycin model of collagen synthesis and fibrosis. Exp Dermatol 2008; 17: 286. (abstract).
80. Raap U, Brzoska T, Sohl S, Path G, Emmel J, Herz U, Braun A, Luger T, Renz H. A-melanocyte-stimulating hormone inhibits allergic airway inflammation. J Immunol 2003; 171: 353-359.
81. Nishida T, Miyata S, Itoh Y, Mizuki N, Ohgami K, Shiratori K, Ilieva IB, Ohno S, Taylor AW. Anti-inflammatory effects of α-melanocyte-stimulating hormone against rat endotoxin-induced uveitis and the time course of inflammatory agents in aqueous humor. Int Immunopharmacol 2004; 4: 1059-1066.
82. Jahovic N, Arbak S, Tekeli O, Alican I. A-melanocyte stimulating hormone has beneficial effects on cerulein-induced acute pancreatitis. Peptides 2004; 25: 129-132.
83. Gonindard C, Goigoux C, Hollande E, D'Hinterland LD. The administration of an α-MSH analogue reduces the serum release of IL-1α and TNFα induced by the injection of a sublethal dose of lipopolysaccharides in the BALB/c mouse. Pigment Cell Res 1996; 9: 148-153.
84. Lipton JM, Ceriani G, Macaluso A, McCoy D, Carnes K, Biltz J, Catania A. Anti-inflammatory effects of the neuropeptide α-MSH in acute, chronic, and systemic inflammation. Ann N Y Acad Sci 1994; 741: 137-148.
85. Bohm M, Wolff I, Scholzen TE, Robinson SJ, Healy E, Luger TA, Schwarz T. Schwarz A. α-Melanocyte-stimulating hormone protects from ultraviolet radiation-induced apoptosis and DNA damage. J Biol Chem 2005; 280: 5795-5802.
86. Jo SK, Lee SY, Han SY, Cha DR, Cho WY, Kim HK, Won NH. α-Melanocyte stimulating hormone (MSH) decreases cyclosporine a induced apoptosis in cultured human proximal tubular cells. J Korean Med Sci 2001; 16: 603-609.
87. Hill RP, Wheeler P, MacNeil S, Haycock JW. A-melanocyte stimulating hormone cytoprotective biology in human dermal fibroblast cells. Peptides 2005; 26: 1150-1158.
88. Lee SY, Jo SK, Cho WY, Kim HK, Won NH. The effect of alpha-melanocyte-stimulating hormone on renal tubular cell apoptosis and tubulointerstitial fibrosis in cyclosporine A nephrotoxicity. Transplantation 2004; 78: 1756-1764.
89. Li C, Shi Y, Wang W, Sardeli C, Kwon TH, Thomsen K, Jonassen T, Djurhuus JC, Knepper MA, Nielsen S. Frokiaer J. α-MSH prevents impairment in renal function and dysregulation of AQPs and Na-K-ATPase in rats with bilateral ureteral obstruction. Am J Physiol Renal Physiol 2006; 290: F384-F396.
90. Valverde P, Manning P, Todd C, McNeil CJ, Thody AJ. Tyrosinase may protect human melanocytes from the cytotoxic effects of the superoxide anion. Exp Dermatol 1996; 5: 247-253.
91. Hadley ME, Dorr RT. Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization. Peptides 2006; 27: 921-930.
92. Hoch M, Eberle AN, Wagner U, Bussmann C, Peters T, Peterli R. Expression and localization of melanocortin-1 receptor in human adipose tissues of severely obese patients. Obesity 2007; 15: 40-49.
93. Thody AJ, Fisher C, Kendal-Taylor P, Jones MT, Price J, Abraham RR. The measurement and characterisation by high pressure liquid chromatography of immunoreactive α-melanocyte stimulating hormone in human plasma. Acta Endocrinol 1985; 110: 313-318.
94. Hoggard N, Johnstone AM, Faber P, Gibney ER, Elia M, Lobley G, Rayner V, Horgan G, Hunter L, Bashir S, Stubbs RJ. Plasma concentrations of α-MSH, AgRP and leptin in lean and obese men and their relationship to differing states of energy balance perturbation. Clin Endocrinol 2004; 61: 31-39.
95. Katsuki A, Sumida Y, Murashima S, Furuta M, Araki-Sasaki R, Tsuchihashi K, Hori Y, Yano Y, Adachi Y. Elevated plasma levels of α-melanocyte stimulating hormone (α-MSH) are correlated with insulin resistance in obese men. Int J Obes Relat Metab Disord 2000; 24: 1260-1264.
96. Donahoo WT, Hernandez TL, Costa JL, Jensen DR, Morris AM, Brennan MB, Hochgeschwender U, Eckel RH. Plasma α-melanocyte-stimulating hormone: sex differences and correlations with obesity. Metabolism 2009; 58: 16-21.
97. Gavrila A, Chan JL, Miller LC, Heist K, Yiannakouris N, Mantzoros CS. Circulating melanin-concentrating hormone, agouti-related protein, and alpha-melanocyte-stimulating hormone levels in relation to body composition: alterations in response to food deprivation and recombinant human leptin administration. J Clin Endocrinol Metab 2005; 90: 1047-1054.
98. Nam SY, Kratzsch J, Kim KW, Kim KR, Lim SK, Marcus C. Cerebrospinal fluid and plasma concentrations of leptin, NPY, and alpha-MSH in obese women and their relationship to negative energy balance. J Clin Endocrinol Metab 2001; 86: 4849-4853.
99. Greenfield JR, Miller JW, Keogh JM, Henning E, Satterwhite JH, Cameron GS, Astruc B, Mayer JP, Brage S, See TC, Lomas DJ, O'Rahilly S, Farooqi IS. Modulation of blood pressure by central melanocortinergic pathways. N Engl J Med 2009; 360: 44-52.
100. Cardones AR, Grichnik JM. α-Melanocyte-stimulating hormone-induced eruptive nevi. Arch Dermatol 2009; 145: 441-444.